Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 10.02B 1.48B 1.29B 1.19B 1.1B 2.09B 141B 2.13B 14.25B 5.6B 69.45B 5.55B 5.43B 239B P/E 2026 *
14.9x
P/E 2027 * 12.4x
Enterprise Value 10.02B 1.48B 1.29B 1.19B 1.1B 2.09B 141B 2.13B 14.25B 5.6B 69.45B 5.55B 5.43B 239B EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.11x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day-2.31%
1 week+1.66%
Current month+7.54%
1 month-0.30%
3 months-8.68%
6 months-18.16%
Current year-16.96%
1 week 22.52
Extreme 22.52
24.24
1 month 21.22
Extreme 21.22
24.24
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.31%+1.66%-16.06%-13.89% 1.48B
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.29%-2.88%+22.44%+49.64% 357.54B
Weighted average by Cap. -1.32%-2.96%+36.73%+83.87%

Financials

2026 *2027 *
Net sales 4.32B 637M 557M 514M 475M 900M 60.74B 916M 6.14B 2.41B 29.92B 2.39B 2.34B 103B 4.75B 701M 613M 566M 522M 991M 66.87B 1.01B 6.76B 2.65B 32.94B 2.63B 2.58B 113B
Net income 674M 99.4M 86.95M 80.2M 74.07M 141M 9.48B 143M 958M 376M 4.67B 373M 365M 16.06B 745M 110M 96.11M 88.65M 81.87M 155M 10.48B 158M 1.06B 416M 5.16B 413M 404M 17.75B
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
10/07/26 CNY 23.25 -2.31% 7,708,440
09/07/26 CNY 23.80 +2.28% 9,739,200
08/07/26 CNY 23.27 +2.06% 5,155,200
07/07/26 CNY 22.80 -1.51% 3,776,101
06/07/26 CNY 23.15 +1.22% 5,155,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.25CNY
Average target price
36.25CNY
Spread / Average Target
+55.91%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock